Skip to main content
logo
Akoya Biosciences, Inc. (AKYA)
Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)
1.290
0.00 (0.00%)
Inactive · Last trade price on Jul 7, 2025

Akoya Biosciences Revenue

Akoya Biosciences had revenue of $16.64M in the quarter ending March 31, 2025, a decrease of -9.32%. This brings the company's revenue in the last twelve months to $79.96M, down -14.55% year-over-year. In the year 2024, Akoya Biosciences had annual revenue of $81.67M, down -15.48%.

Revenue (ttm)
$79.96M
Revenue Growth
-14.55%
P/S Ratio
0.80
Revenue / Employee
$390,054
Employees
205
Market Cap
64.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202481.67M-14.96M-15.48%
Dec 31, 202396.63M21.77M29.09%
Dec 31, 202274.86M19.94M36.31%
Dec 31, 202154.92M12.47M29.39%
Dec 31, 202042.44M207.00K0.49%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

AKYA News

More News